1.04
0.11 (11.23%)
| Previous Close | 0.935 |
| Open | 0.958 |
| Volume | 326,974 |
| Avg. Volume (3M) | 796,562 |
| Market Cap | 40,184,196 |
| Price / Sales | 0.950 |
| Price / Book | 4.01 |
| 52 Weeks Range |
| Profit Margin | -15.05% |
| Operating Margin (TTM) | -35.80% |
| Diluted EPS (TTM) | -0.140 |
| Quarterly Revenue Growth (YOY) | 161.90% |
| Total Debt/Equity (MRQ) | 38.14% |
| Current Ratio (MRQ) | 2.66 |
| Operating Cash Flow (TTM) | -2.72 M |
| Levered Free Cash Flow (TTM) | -2.37 M |
| Return on Assets (TTM) | -12.72% |
| Return on Equity (TTM) | -35.68% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Myomo Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -1.5 |
| Average | 0.40 |
|
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 7.05% |
| % Held by Institutions | 60.47% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Clearstead Advisors, Llc | 31 Mar 2026 | 425,600 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| HENRY DAVID A | - | 1.10 | -5,166 | -5,683 |
| Aggregate Net Quantity | -5,166 | |||
| Aggregate Net Value ($) | -5,683 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 1.10 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| HENRY DAVID A | Officer | 13 Jul 2026 | Disposed (-) | 5,166 | 1.10 | 5,683 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |